CHICAGO, IL / ACCESS Newswire / February 5, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a ...

Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, ...

Ms Harris, who was diagnosed with multiple sclerosis (MS) in 2007, told the staff member the dog was wearing an assistance ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

Mothers with multiple sclerosis had an elevated incidence and prevalence of peripartum mental illness vs. mothers without MS ...

Adia Nutrition's diverse portfolio, including its groundbreaking work in stem cell therapy through Adia Med, has positioned the company as a pioneer in the health sector. The anticipated uplisting is ...